GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis
about
Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide ReceptorGlucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocinAttenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob miceAn enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice.Pursuit of a perfect insulin.Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.Gut: A key player in the pathogenesis of type 2 diabetes?Glucose-dependent insulinotropic polypeptide directly induces glucose transport in rat skeletal muscle.A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents.Gut hormone polyagonists for the treatment of type 2 diabetes.Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes.Are peptide conjugates the golden therapy against obesity?
P2860
Q27678197-81133F81-3331-4BA1-9875-6EC77EE275BAQ33603384-54F1CB31-F57F-4495-A16B-651436C63F03Q36990110-922FD607-3F07-417E-A20D-CE5F7F1DD73EQ37662974-A7FA9A65-4B0F-4170-BAD5-6CB7BCB78468Q38724829-6E79DF69-D165-4F92-8D3E-0F5946D3533AQ38778988-6E25A190-6D11-4593-8FD9-EB9E4846A05EQ38830154-74B3EE38-95A7-4C88-B13B-D7BB21E5311CQ39021924-EDB9F024-8441-400C-B57D-CC69F1187B76Q40871757-EE9BC64F-8503-486C-8890-19B31227C60CQ47207365-FD2C6755-6297-4FA7-90F2-0EA4BE69FAC8Q49218095-58A3B797-879C-4D59-92B6-3D42FD40A739Q54475659-DA450752-EC67-45F3-9642-B96FD5B158F8Q55427238-FA2D3143-74B1-4B84-8E7D-F611426C58BA
P2860
GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@ast
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@en
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@nl
type
label
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@ast
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@en
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@nl
prefLabel
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@ast
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@en
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@nl
P2093
P2860
P1433
P1476
GIP-overexpressing mice demons ...... d improved glucose homeostasis
@en
P2093
Carlos M Isales
Christopher H S McIntosh
Cuilan Nian
Su-Jin Kim
Subashini Karunakaran
P2860
P304
P356
10.1371/JOURNAL.PONE.0040156
P407
P50
P577
2012-07-03T00:00:00Z